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Abstract
Background: The diagnosis of prostate cancer (PC) can provide a trigger for dietary change, and there is evidence
that healthier diets may improve quality of life and clinical outcomes. However, men’s views about dietary change
in PC survivorship are largely unknown. This multi-centre qualitative interview study explored men’s views about
dietary change in PC survivorship, to better understand motivations for, and barriers to, achieving desired changes.
The role of radical and active surveillance treatments on dietary change and the influence of men’s partners were
examined. Focus groups also evaluated stakeholder opinion, including healthcare professionals, about the provision
of dietary advice to PC patients.
Methods: A multi-centre interview study explored views about diet and motivations for, and barriers to, dietary
change in men at elevated risk or diagnosed with PC following prostate specific antigen (PSA) testing. 58 men and
11 partners were interviewed. Interviews and focus groups were undertaken with 11 healthcare professionals, 5 patients
and 4 partners to evaluate stakeholders’ opinions about the feasibility and acceptability of providing dietary advice to PC
patients. Data were analysed using methods of constant comparison and thematic analysis.
Results: Over half of diagnosed men reported making dietary changes, primarily to promote general or prostate health
or facilitate coping, despite their uncertainty about diet-PC links. Interest in dietary advice was high. Information needs
varied depending on treatment received, with men on active surveillance more frequently modifying their diet and
regarding this as an adjunct therapy. Men considered their partners integral to implementing changes. Provision of
dietary advice to men diagnosed with PC was considered by healthcare professionals and men to be feasible and
appropriate in the context of a holistic ‘care package’.
Conclusions: Many men make positive dietary changes after PC diagnosis, which are perceived by men and their
partners to bring psychological and general health benefits and could help future dietary intervention trials. Men and
their partners desire more and better dietary information that may support PC survivorship, particularly among those
embarking on active surveillance/monitoring programmes. There are opportunities for healthcare professionals to
support PC patients both clinically and psychologically by the routine integration of healthy eating advice into
survivorship care plans.
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Background
Prostate cancer (PC) is the second most common cancer
in men and incidence rates may double by 2030 [1].
With increased awareness and levels of prostate specific
antigen (PSA) testing and improved treatment strategies,
the number of men living with the disease is also rising
[2]. Growing evidence indicates that a healthy diet may
improve overall clinical outcomes [3,4] and quality of life
[5,6] in cancer, with the strongest evidence regarding PC
for a protective effect from foods containing lycopene, a
component of tomatoes [3].
Some previous research indicates that around half of
men change their diet after PC diagnosis [7-9]. However,
the factors motivating or preventing men at elevated risk
or diagnosed with PC from achieving desired changes,
and their attitudes about dietary advice, are poorly
understood. It is recognised, furthermore, that social
support can assist healthy eating and successful dietary
change in patients with other diseases (e.g. cardiovas-
cular disease, Type II diabetes) [10,11]. There has been
no empirical interview research comparing the impact
of different radical and non-radical PC treatments on
men’s dietary decisions. Identifying facilitators and ob-
stacles to dietary change may also inform the design of
dietary intervention trials, where initiating and sustain-
ing dietary changes is frequently problematic and diffi-
culties with compliance and attrition often arise [12].
The views of stakeholders (e.g. patients and their part-
ners, healthcare providers and researchers) about the
provision of dietary advice to men diagnosed with PC
are uncertain and men’s experiences and perceptions
of being given dietary information after a PC diagnosis
are also uncertain. This interview study explored views
about diet and motivations for and barriers to dietary
change in men at elevated risk and those diagnosed
with PC. This included the possible role of different
radical and non-radical treatments received and the
influence of men’s partners on dietary change. Subse-
quent interviews and focus groups with healthcare pro-
fessionals, patients and their partners also sought to
evaluate stakeholders’ opinions about the feasibility
and acceptability of the routine provision of dietary ad-
vice to PC patients within the NHS.
Methods
Sampling
The aim was to include a wide range of participants, in-
cluding patients, partners and health professionals from
different settings and with different experiences of pros-
tate cancer diagnosis, survivorship or healthcare. Several
sampling strategies, including maximum variation pur-
posive (non-probability) sampling, were used to ensure
the inclusion of the range of characteristics of the popu-
lation, including the recruitment of men participating in
the ongoing ProtecT (Prostate Testing for Cancer and
Treatment) randomised treatment trial [13]. Data derived
from food frequency questionnaires (FFQ) completed by
ProtecT men before and one year post-diagnosis were also
used to ensure participants were sampled across the range
of degrees of dietary change.
Participants and recruitment
There were three sets of participants (Figure 1 and
Table 1):
(i) Men diagnosed with PC and their partners in two
settings: The first group were recruited from the
ProtecT trial. In ProtecT, men registered with primary
care centres in nine UK areas aged 50–69 with no
history of PC received mailed information and a
recruitment clinic appointment for a PSA test. Men
with a raised PSA result (≥3.0 ng/ml) were invited for
transrectal ultrasound-guided biopsy and those diag-
nosed with clinically localised disease were offered
randomisation to radical prostatectomy, conformal ex-
ternal beam radiotherapy or active monitoring (AM),
a form of surveillance that comprised regular sched-
uled assessments of PSA levels and disease status and
is comparable to active surveillance (AS - close moni-
toring of prostate specific antigen levels combined
with periodic imaging and repeat biopsies) without
scheduled biopsies. For the purposes of this qualitative
study, ProtecT men and their partners were inter-
viewed at varying timepoints after diagnosis. The sec-
ond group were men diagnosed with localised PC by
their primary care centre and who subsequently par-
ticipated in a study investigating clinical outcomes of
AS (the ‘Active Surveillance Study’, Royal Marsden
Hospital, UK). A sample of these men was interviewed
after commencing AS.
(ii) Men at elevated risk of PC: Men were recruited
from the nested ProDiet study, which was
investigating the feasibility of recruiting men from
the ProtecT study with a PSA level of 2.0-2.9 ng/ml
or ≥3.0 ng/ml with a negative biopsy into a
randomised dietary modification trial. Men who
consented were randomised to both a lycopene
(active capsules, placebo capsules or 1–2 portions of
cooked tomatoes per day) and a green tea dietary
component (active capsules, placebo capsules or 3
cups of green tea per day) for six months. A sample
of these men was interviewed immediately after
randomisation.
(iii) Stakeholders: A stakeholder evaluation, using
focus groups and interviews, was undertaken to
explore views about the routine provision of dietary
advice to men diagnosed with or at elevated risk of
PC. Key stakeholders were invited, including 18
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service providers (healthcare professionals and
support group workers) identified from local
hospitals, academic institutions and primary care
practices, 9 men diagnosed with PC in the ProtecT
study and 5 of their female partners.
Data collection
Data collection comprised two phases.
Phase 1 - Patient and partner interviews: The aim
of these interviews was to explore participants’ views
about prostate cancer and diet. Of the 61 men and 11
partners of men invited for interview by the study
researcher (KA) between January 2008 and March
2012, 69 (58 men and 11 female partners; 96%) agreed
(Figure 1). Interviews were conducted between 7–42
months post-diagnosis and lasted 9–90 minutes. Partners
were interviewed simultaneously or separately depending
on the couples’ preferences. Interviews were semi-
structured using topic guides informed by literature
review and discussion between study researchers.
Interviews were conducted in the participant’s home
(n = 46) or by telephone (n = 23).
Phase 2 - Stakeholder evaluation: Interviews and a
focus group were undertaken with key stakeholders to
examine their interpretation of and opinions towards
current evidence linking prostate cancer to diet, and
their attitudes and preferences about the provision and
communication of dietary advice post-diagnosis. Of the 9
men/partners invited, a focus group was conducted with
5 men diagnosed with PC in the ProtecT study (response
rate 56%, mean age 68.3 years) and 4 of their partners (re-
sponse rate 80%, mean age 68.0 years). Of the 18 invited,
in-depth interviews were conducted with 11 service
providers (61%, 6 male, 5 female, mean age 46.2 years),
including Consultant Urologists/Oncologists (n = 4), die-
ticians (n = 3), public health nutritionists, primary care
practitioners, Uro-oncology specialist nurses and prostate
cancer support group worker (one of each). Participants
Figure 1 Flow diagram of study recruitment. aRoyal Marsden Hospital, bUniversity of Bristol, cUniversity of Bristol, dietary modification
comprised a lycopene component (active capsules, placebo capsules or 1–2 portions of cooked tomatoes per day) and a green tea component
(active capsules, placebo capsules or 3 cups of green tea per day).
Table 1 Participant characteristics (n = 69)
Localised PCa
(n = 37)
Elevated riskb
(n = 21)
Partnersc
(n = 11)
Mean age,
years (range)
66.5
(54.4– 75.4)
65.4
(52.5 – 72.3)
65.1
(59.8 – 72.2)
Mean PSA level,
ng/ml (range)
5.6 (3.0 – 12.9) 3.0 (2 – 9.2) N/A
Treatment, n - N/A -
Active monitoring/
surveillance
15 4d
Radical radiotherapy 12 2d
Radical prostatectomy 9 5d
Brachytherapy 1 0d
Marital status, n
Married/living as
married
31 21 11
Not married 6 0 0
Occupational classe, n
Managerial &
professional
13 11 2d
Intermediate 8 3 3d
Working 11 7 6d
N/A = not applicable, PSA = Prostate Specific Antigen, aincluding 32 men in
ProtecT study and 5 men in AS study, bPSA 2.0-2.9 ng/ml or ≥3.0 ng/ml with a
negative biopsy, included in ProDiet study, cof ProtecT participant, dof ProtecT
man, ebased on participant’s occupation using the three-class system [35],
not available for Active Surveillance Study participants.
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were presented with a summary of the World Cancer Re-
search Fund’s (WCRF’s) Expert Report on food, nutrition
and PC prevention [3], the most recent summary of the
literature to date, during the focus group. A topic guide
was used to evaluate the extent of stakeholders’ existing
knowledge about the role of diet in PC prevention prior
to being presented with a summary of the WCRF report
and attitudes about the provision of dietary advice to PC
patients. The focus group lasted 107 minutes and the in-
terviews 19–52 minutes.
Analyses
Interviews and the focus group were conducted by KA,
audio-recorded, transcribed and analysed using NVivo9
software. Analyses were conducted by KA to inductively
identify recurring themes (concepts or explanatory ideas)
from the data, via line-by-line coding of textual data,
and to examine relationships between them [14,15].
Themes were then assigned brief descriptive codes.
After transcripts had been coded, emerging themes were
compared with newly-collected data to test and refine
themes [16]. Where appropriate, themes were categorised
to facilitate higher-level interpretation of the data. Sampling
and analyses continued until no new themes were emerging
and established themes ceased evolving. A subset of inter-
views was independently analysed by a second researcher
(JH, JW) and coding discrepancies discussed to maximise
rigour and reliability. Plausibility of data interpretation was
further discussed between the study team throughout the
analyses (JD, AL, JW, KA) and ‘negative’ cases, in which re-
spondents’ perspectives or experiences differed from the
main body of evidence, were sought to explore participants’
divergent views and to enhance the credibility of the ana-
lyses and results [16]. Quotations from a range of respon-
dents are provided below to illustrate themes that emerged
during the analyses where the prefix Pn denotes a ProtecT
participant, Fn his partner, Dn a ProDiet participant, An an
Active Surveillance study participant and Sn a service
provider or healthcare professional participant. The charac-
ters … denote omitted text. Ellipses ( … ) contain a refer-
ence to a person’s name.
Ethical approval for this interview/focus group study,
the ProtecT study and the ProDiet study was obtained
from Trent Multi-centre REC (MREC/01/4/025–21/06/
2001, 09/H0405/37–12/11/2009 and ProDiet 08/H0405/
61) and for the AS study from the Royal Marsden REC.
Written or verbal informed consent was obtained from
all participants.
Results
Interviews with men at elevated risk or diagnosed with
PC and their partners were conducted with participants
from a range of age groups, trial recruiting centres, pre-
diagnosis PSA levels and treatments (Table 1). Reflecting
the demographics of the studies from which participants
were sampled, most (68, 98.6%) were from White ethnic
groups.
Men’s perceptions of the cause of prostate cancer
Men at elevated risk or diagnosed with PC typically
expressed uncertainty about causes of PC and the poten-
tial role of diet in PC aetiology. Consequently, men rarely
attributed their disease to dietary causes: “I think there are
many other factors which are much more important … for
example genetic background, I think all have a much more
significant role than things like diet” (P3).
Triggers, facilitators and barriers to dietary change
Men were mostly uncertain about whether diet could
help manage or prevent progression or recurrence of
disease. However, over half (22) of the 37 men with PC
reported changing their diet post-diagnosis, most com-
monly eating more tomatoes/tomato products, more
fruits and vegetables or decreasing fat intake. Fifteen
men had improved their diet previously, e.g. after experi-
encing high cholesterol, but a PC diagnosis often served
as a ‘wake-up call’ or extra incentive to consider dietary
improvements to enhance their general and, subse-
quently, their prostate health (see the ‘List of examples
of reasons for dietary change in men diagnosed with
PC’). Dietary change also served as a coping strategy for
some men, with four describing feeling they were ‘doing
something’ to help and two explaining that focusing on
dietary changes helped them manage their uncertainty
and regain some control over their disease and their fu-
ture survivorship. Similar feelings were expressed by
men at elevated risk.
List of examples of reasons for dietary change in
men diagnosed with PC
PC diagnosis as an incentive
P4: I can’t say it was definitely because of the
prostate I think we had already decided before that
was even diagnosed that we would try and eat a little
bit healthier shall we say you know I’m 60 now …
Maintaining general health after diagnosis
P30: … I think it’s just the general thing just to look
after your health through eating healthily. How much
it’s related to any cancer I’ve no idea really.
Preventing progression and/or recurrence or to be
‘fighting fit’ for further treatment
P7: Well to restrict the cancer from spreading as
much as anything.
F6: … no I don't think it's (diet) going to prevent
cancer no … I just think it probably reduces the
risks … to generally, sort of, keep yourself healthy so
you've got the best chance if it recurs.
Curing PC
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P14: (the author of a published anti-cancer diet) had
her cancer gradually diminished and I was hoping
that would be the same with mine … curing it …
Preventing other cancers
P11: … you just hope that it will, well one make you
more healthy … and two, I suppose hopefully reduce
risks, um, whatever they are in the future for any
other cancer I suppose.
Positive psychological effects of ‘doing something’
P11: … you feel more positive I think, you know,
you sort of, you're doing something, you know.
P5: … I suppose it could be classified partly
psychological, it’s doing some good … the hope it was
all going to help.
P22: … my established method of managing
uncertainty is to find out about it … that’s where I
get my control back, I manage my emotions by being
more rational it’s a denial strategy … an avoidance
strategy.
Diet believed to cause PC
P24: … physically I earned it (the PC diagnosis) … I
ate all the wrong things and drank all the wrong
things .... And that’s when I embarked upon the
programme that being very choosy about what I
eat ....
Receiving dietary advice/information
P1: … I did read that, tomatoes, fresh tomato juice
is good for so I was on that for quite a while.
P20: Well you hear snippets of information about
what you should be eating and drinking … anyway I
stopped taking copious amounts of orange juice and
changed to cranberry and pomegranate juice.
Receiving information (e.g. from a family member,
health professional, media) about potential diet-PC
links triggered six PC patients to make changes. Irre-
spective of whether they made changes, most men
expressed confusion and dissatisfaction with available
dietary information and/or its contradictory nature.
Notably, most non-changers of diet (11 out of 15 men)
described unreliable information as a barrier to making
dietary changes.
Perceived relationship between PC treatment and
dietary change
In men diagnosed with PC, treatment type, particularly
its perceived success, greatly influenced attitudes toward
potential benefits of dietary changes post-diagnosis (see
the ‘List of examples of the impact of PC treatment on
dietary change’). Men who received radical treatment
(radiotherapy, prostatectomy or brachytherapy) were more
likely to describe their treatment as ‘successful’, and their
PC as ‘cured’ (P4,8,10,11,13), than those on AM or AS.
Consequently, these men more often regarded dietary
changes as unlikely to be beneficial, with a number dis-
closing that they may have considered changing their diet
more had they not had radical treatment. In contrast, men
on AM or AS were slightly more likely to change their diet
(10/15 men on AM versus 5/9 men who had surgery and
6/12 of men who had radiotherapy). Men on AM or AS
more often regarded dietary changes as an adjunct ther-
apy. Some described positive psychological effects associ-
ated with ‘doing something’ potentially beneficial to
manage/control their disease. This view was also shared by
some men who underwent radiotherapy, with two reflect-
ing that they may have changed their diet less had they re-
ceived ‘curative’ surgery.
List of examples of the impact of PC treatment on
dietary change
Dietary change unnecessary due to ‘curative’
treatment
P11 (surgery): … I've just parked it. I’ve had it done.
I’ve dealt with it …
P4 (surgery): … if I had taken part in doing
(radiotherapy or active monitoring) I think I would
have been a bit more conscious of what I would eat
and what I wouldn’t eat to try and keep it at bay …
the fact that I’ve had the prostate out, that’s at the
back of my mind really … so I’m living a normal
life …
P9 (radiotherapy): Well I’m not really expecting it to
come back again anyway so therefore do I have to
change my diet …
P1 (radiotherapy): … now that I’ve got rid of my
cancer … I suppose there’s a feeling that I don’t have
to control my cancer … (had I been on active
monitoring) I would have tried everything then of
course … I would probably be drinking a gallon of
tomato juice a day cos they say it’s good for you.
P12 (active monitoring): I don’t know if there would
be any need to take the lycopene … if the prostate
had been removed.
Dietary change as an adjunct therapy to active
monitoring and radiotherapy
P12 (active monitoring): … it’s something positive isn’t
it, you know, taking something, so it might help. … at
the moment I’m on active monitoring, so as I isn’t being
checked … I’m getting no other treatment am I? … I
just felt that by sort of, if I can do anything that might
help slow it up then I would.
P7 (active monitoring): So I’ve changed my diet, seen
how that’s gone and initially my PSA reading dropped
down … and then come back up … and so I seem to
sort of hit a limit on what I can do with just tomatoes
and now I’m going to be looking at alternative
supplementation to see if there is something in there
that would help (reduce) the cancers.
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P30 (radiotherapy): … I was getting medical
treatment so diet seemed to be the only thing I could
do. I thought it’s no good having treatment and
eating all types of food so I sort of had the idea that
one negates the other …
Nothing to lose
P24 (radiotherapy): Whether (dietary change is
beneficial) at such a late stage as I am, already having
been diagnosed and treated I’m not sure about that
but I work on the principal what harm can it do?
Influence of men’s partners on dietary change
Men’s partners played a significant and multi-faceted
role in their diets (see the ‘List of examples of the influ-
ence of partners on men's diet and men's dietary change’)
and men often used plural terminology (e.g. ‘we’, ‘us’) re-
ferring to dietary decisions being made jointly. Whilst
partners more often assumed responsibility for food pur-
chasing and preparation, decisions about meal choices
were mostly jointly made. Consequently, men typically
described having considerable control or responsibility
over their diet. Decisions to change diet were also often
made jointly, though men’s partners were most com-
monly responsible for implementing these by buying
food and preparing meals. Only three men (P4, P9, P11)
acknowledged that dietary change was initiated solely by
their partner but apparently not against their wishes.
One man (P9), for example, reported that he would not
have started taking selenium tablets had his wife not initi-
ated this. The nature of dietary changes made was also
sometimes influenced by their partner’s food preferences
(e.g. a partner’s dislike of red meat helped one man to suc-
cessfully reduce his intake). Regardless of who initiated
dietary changes, the role men’s partners played in
implementing and maintaining dietary changes often
reduced men’s perception of responsibility in the
process, making change easier. Some women explained
how they would consider influencing their partner’s di-
ets should dietary advice for PC become available.
Some men (e.g. P11) felt that women are more
knowledgeable about diet in relation to health, partly
because dietary information is targeted at and more
readily available to women in the media (e.g. in maga-
zines). Only one woman (F1) expressed concern that
their husband would be unwilling to change his diet.
List of examples of the influence of partners on
men's diet and men's dietary change
The use of plural terminology
P7: We’ve tried, yep we do try to eat more fruit,
again partly with the eye on the prostate cancer
thing, yes.
Joint decision-making regarding dietary decisions
and dietary change
P12: … they (the ProtecT study nurses) told like they
told me at certain meetings (PSA check clinics) that
some things are good and then I come home and
tell (my wife) and then we try and implement it…
P1: I think it (changing diet) would be quite an easy
thing to do, um, although I would have to
programme my wife to stop buying the things that
I like.
Partner-driven dietary changes
P11: Oh ((patient’s wife)) would, um, keep nudging
me like: oh you should eat, you know, less of that or.
No, I think certainly, uh, I think the, um, the woman
in the house I think is a lot more switched on to
things like that.
P4: … I mean the wife not really pressurised, she just
sort of said oh you know maybe we ought to do a
little bit differently.
P11: … I don’t make the effort but I don’t have to
because… it’s being done for me. And so it makes
it easier.
Mechanisms of bringing about dietary change
F4: I think it’s (dietary decisions) a joint thing but I
think if I’d read somewhere that he definitely had to
eat something, I would make sure that he ate it by
hook or by crook like I did with the boys, I’d mix it
in with the potatoes or something.
Interest in dietary advice and information following
diagnosis
Interest in dietary advice was high among men both at
elevated risk and men diagnosed with PC, and their
partners. Information needs post-diagnosis varied some-
what according to men’s perceptions of their treatment
success and disease status, with one man on AM explain-
ing “well I have prostate cancer, I would probably pay
strong attention to (dietary advice)” (P7) and another who
felt cured after radiotherapy requesting dietary informa-
tion that “would make a difference to my well being …
now that I am hopefully cancer free, I want to stay that
way …” (P1). Only one man considered dietary advice ir-
relevant because he considered himself ‘cured’.
Men said they would welcome scientific and evidence-
based dietary advice that became available: “… if it came
from a reliable source and it weren’t just a maybe will
you try this just in case” (P26). For dietary advice to be
considered ‘trustworthy’, men stressed that it should
come from authoritative and reputable sources, typically
health professionals directly involved with their care (e.g.
their primary care physician, hospital consultant or
nurse). Some men acknowledged that their partner’s in-
volvement would be integral to acting on dietary advice
because “… many men are passive in the house … it
needs to go through the women …” (P7).
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Healthcare professionals’ support for provision of dietary
information to enhance survivorship
Both men and stakeholders described that men were
rarely given dietary advice by their healthcare profes-
sional after their PC diagnosis. In the absence of
convincing evidence in the literature of diet-PC links,
some healthcare professionals indicated uncertainty
about what information to provide patients, with most
reporting that they did not routinely initiate discussion
of dietary change with PC patients (see the ‘List of ex-
amples of health professionals’ opinions about the rou-
tine provision of dietary information to PC patients’).
Most men, and their partners, reported that they would
welcome and consider acting upon dietary advice should it
become available, supporting findings from the in-depth
interviews described above.
List of examples of health professionals' opinions
about the routine provision of dietary information to
PC patients
Uncertainty over what dietary information to provide
S1 (General Practitioner): … if someone came into
me and said you know ‘well what’s the info doc?’ …
I’d have to look that up because I don’t know and I
wouldn’t know where to go for ready access to the
data to support any discussions about that.
S6 (Consultant Urologist): … the short answer to it is
yes I do give dietary advice to those that want it but
probably I should be giving more advice to everybody
but I haven’t done it up to recently you know
because I’m not entirely sure what to say.
S6 (Consultant Urologist): I think there is some
evidence and I’m sure it will come; it’s just a matter
of time. Just because there isn’t any evidence doesn’t
mean that you can’t, it doesn’t mean that it’s not
right to offer dietary advice so I think the way you
put it earlier was the best way is that here’s what we
know, make your own mind up you know and I think
that’s all that is is just empowering the patient, giving
him the information and let them make the decision.
Benefits for general health
S1 (General practitioner): … modifying diet in any
cancer process is beneficial and I would probably
from my current stand point take that sort of tack in
it talking about cancer in general rather than
probably being informed enough to specifically talk
about prostate cancer.
S3 (Dietician): … there isn’t any harm anything there
so that would be quite good you know they’ve got
other benefits as well. And it’s a really positive thing
that people can do.
S6 (Consultant Urologist): When they do bring it up
I say yea it’s a good idea to have a healthy diet
because basically the sorts of the foods that we are
talking about that are good for prostate cancer also
are good for the other things that affects male
health which is basically cardiac disease, so
improving your diet anyway with, maybe, beneficial
to prostate cancer although we haven’t actually
certainly proven that yet is definitely going to be
beneficial for general health, diabetes and heart
disease and therefore I say to them go for it, it’s a
good idea, it won’t do you any harm and it might
just do some good.
S9 (Consultant Oncologist/Consultant Urological
Surgeon): … it (dietary change) can’t be touted as
‘this will make your prostate cancer outcome better’.
I think what it should be touted at until you get more
information is that look, this appears to be useful, at
the very worst it’s going to give you, you’re going to
eat a healthier diet which is going be better for you
anyway so and that’s a fairly pragmatic approach but
I think that’s fairly sensible at the moment, and
bearing in mind the whole selenium, vitamin E
debacle, not a debacle but that’s actually a very good
study that needed to be done.
Benefits for active surveillance patients
S6 (Consultant Urologist): We don’t know but it
might be more relevant … to men for example who
are on active surveillance for their prostate cancer
who’ve got low risk low volume prostate cancer.
Role of the healthcare professional
S5 (Consultant Urological Surgeon): … the
consultant who might be doing the operations …
then people listen.
S5 (Consultant Urological Surgeon): … we’ve
(consultants have) got a captive audience. GPs they
see as generic filter don’t they?
S6 (Consultant Urologist): … if it comes from a
doctor well they tend to listen a bit more sometimes.
Timing
S2 (PC survivor and PC support group organiser):
they will have to go back, see their consultant to
decide what sort of treatment they going to get and
then I think it’s probably at that time that they
should be told perhaps about diet ‘cause it’s all part
and parcel of the recovery process hopefully.
S5 (Consultant Urological Surgeon): There’s some
patients who you’d tailor it according to the situation;
some are just so shocked by the diagnosis and their
priority is to get through initial definitive treatment,
get to grips with the diagnosis and what it means but
they don’t consider that (diet) until much later.
Empowering patients
S6 (Consultant Urologist): … and I think that’s all
that (dietary information) is, just empowering the
patient, giving him the information and let them
make the decision.
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S9 (Consultant Oncologist/Consultant Urological
Surgeon): … I think people should take more of a
role in their own care.
A brief lay summary, optimally describing current evi-
dence of foods/nutrients possibly causally related to PC
or, at the very least, tips for general healthy eating were
considered valuable by men, particularly if delivered in
the context of a holistic ‘package of care’ and offered
during the critical ‘teachable moment’ soon after diagnosis
or around the time of treatment during which patients are
more receptive to healthcare promotion activities. However,
some participants did acknowledge that each patient should
be considered individually, to avoid overloading them with
information and causing increased anxiety around the time
of diagnosis (see the ‘List of examples of health profes-
sionals' opinions about the routine provision of dietary in-
formation to PC patients’). Some healthcare providers also
referred to the role dietary information may play in empow-
ering patients and enabling them to be more involved in
their own health (see the ‘List of examples of health profes-
sionals' opinions about the routine provision of dietary
information to PC patients’). All parties agreed that the
information would have greater impact if delivered face-to-
face and preferably by a healthcare professional directly
involved with the patient’s care, particularly the diagnostic/
treatment process (such as an oncologist, urological con-
sultant or surgeon). Inclusion of partners and/or family in
the process of dietary information provision is desirable,
due to their potential role as co-implementers in dietary
change. Men requested that the source of the information
(e.g. the WCRF recommendations) be acknowledged to
offer reassurance that the information comes from a reput-
able and evidence-based source. Written information (e.g.
an information leaflet) was preferred, enabling patients to
refer back to it at their leisure and including links to
sources of further information (e.g. websites). However, op-
portunity to discuss the information provided further and
to obtain feedback on progress with dietary change was
considered valuable.
Discussion
This interview study explored views about diet including
motivations for dietary change in men at elevated risk or
diagnosed with PC. Findings indicated that, despite scep-
ticism and uncertainty about diet-PC links, over half of
men with PC made dietary changes that were generally
‘healthier’ or specifically ‘prostate healthy’ [3]. Dietary
changes were perceived to bring psychological benefit, as
a method of coping, enhancing survivorship or regaining
control. PC treatment also influenced men’s perceptions
of their disease state and whether they made dietary
changes, with those undergoing non-radical treatment
(AS/AM) more likely to perceive dietary changes a
beneficial adjunct therapy than men who had surgery or
radiotherapy. Men’s dietary information needs varied
according to perceptions of treatment success but
most men, including those at elevated risk of disease,
expressed interest in receiving dietary advice. Men’s
partners were considered integral to the success of
dietary change. Overall, the provision of routine diet-
ary advice to men diagnosed with PC was considered
by all parties, including healthcare professionals, to be
both feasible and appropriate in the context of a holis-
tic ‘package of care’.
Men in this study were aged 52–75 and were invited
for community-based PSA testing or diagnosed within
routine clinical practice, and so are comparable to many
contemporary PC patients. Qualitative methods enabled
in-depth exploration of participants’ individual experi-
ences and opinions. Interviews were conducted with 69
participants with a high response rate, including men
with a range of diagnostic PSA levels, men at elevated
risk or diagnosed with localised disease and undergoing
different cancer treatments. Interviews with partners
also allowed the influence of family on dietary decisions
to be explored. Most participants were white and further
exploration in other settings is desirable, particularly in
men different cultural and socioeconomic groups to ex-
plore potential variations in health beliefs and dietary prac-
tices. Participants in the ProDiet intervention trial and the
ProtecT treatment trial (who were asked to complete diet
questionnaires pre- and post-diagnosis) may have had in-
creased awareness of potential diet-PC links, though they
were not routinely given dietary information within the
study. The use of a qualitative method, involving direct
(and mostly face-to-face) discussion between the partici-
pant and the researcher, may have increased the likelihood
that participants would report dietary change, though no
evidence was collected during this study that indicated that
this actually occurred. Participants in research studies are
more likely to practice health behaviours [5] and a control
group was not included, although this study also included
men diagnosed by their primary care physician and outside
a trial context and their findings were comparable.
Many men were motivated to change their diet after
PC diagnosis. This supports recent National Cancer Sur-
vivorship Initiative research highlighting that cancer pa-
tients want to know how to look after themselves,
including how diet and lifestyle changes may help them
to return to a ‘normal’ life [17,18] and previous surveys
reporting that up to half of PC survivors change their
diet to boost immunity and prevent recurrence [7,9,19]
and that men on AS have a need for support services,
including information about eating a healthy diet [20].
In particular, dietary changes reported by men in this
study were often ‘heart healthy’ (e.g. increased fruit and
vegetables, decreased fat and red meat). Recent findings
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from food questionnaire data from ProtecT showed that
a PC diagnosis prompted one third of men to adopt
healthier diets [21].
Research exploring motivations, obstacles and facilita-
tors to dietary change among PC survivors outside of a
trial context has previously been limited. This study sup-
ports findings from previous interview-based research
indicating that men’s decision-making around changing
their diet after a PC diagnosis is a complex process, where
men construct a rationale for dietary change based on con-
sideration of multiple factors, including their pre-cancer
diet perceptions, diet-health understandings, perceptions of
PC and the need to ‘do something’ [22]. The findings from
this study further indicate that changes are often triggered
after diagnosis but that the diagnosis itself may be only one
contributing factor to initiating dietary change, serving as
an ‘extra incentive’. This study also extends findings ob-
served in survivors of other cancers, including prostate can-
cer, that interviewed men feel that dietary changes bring
psychological benefit [6,23,24].
The importance of men’s partners in decision-making,
optimising motivation and enhancing behaviour change
was also emphasised, supporting evidence from men
undergoing AS [20,25] and from other disease areas (e.g.
cardiovascular disease, Type II diabetes) [10,11]. More
recent research taking a ‘gender relational’ approach to
explore health behaviour, has reinforced the stereotype
that, in contrast to women, men are typically uninter-
ested in ‘feminine’ health promotion practices, such as
nutritional self-care, and instead adhere to socially-
constructed masculine ideals about diet that may under-
mine rationales for dietary change [26,27]. However, the
influence of men’s partners on dietary change is uncer-
tain. This study demonstrated that men’s partners played
an integral role in initiating and maintaining dietary
change in male PC survivors, supporting the notion that
the influence of a female partner may challenge masculine-
derived rationales for dietary change (or lack thereof). We
also found that, in contrast to the stereotype, some men
were highly motivated to improve their diet and often as-
sumed an active dietary leadership role. Dietary change
may serve as a way of fostering a sense of confidence and
control, both factors that are considered important to the
stereotypical description of masculinity. Research into the
potential influence of different treatments on men’s dietary
decisions after a PC diagnosis has also been scarce. This
study showed that type of cancer treatment may influence
men’s dietary decisions post-diagnosis, with men on AM/
AS reporting more interest in dietary factors for survivor-
ship than men who received radical treatments. This sup-
ports findings from an interview study in which PC
patients focused on diet as an adjunct therapy and self-
management strategy to overcome AS-related anxiety,
though there were no comparisons with radical treatments
[25]. Recent research from the ProtecT trial further shows
that men undergoing AM consumed more fruit/vegetable
juice (including tomato juice) than those randomised to
surgery [21].
Findings from this study can inform the design of
dietary intervention trials for PC, providing further evi-
dence that a cancer diagnosis offers a “teachable mo-
ment” during which health promotion activities may be
most successfully initiated [19,26]. Previous cancer diet-
ary intervention trials have been hampered by uncer-
tainties over best methods for initiating and maintaining
desired changes [28]. This study has identified a number
of knowledge- and information-based barriers and facil-
itators to dietary change, which may be valuable in
informing future trial design, most notably information
provision and the role of men’s partners.
Improving understanding of dietary behaviour and in-
formation needs of men at elevated risk or diagnosed
with PC may inform the provision of care for these pa-
tients but research exploring the views of key stake-
holders, including men, their partners and healthcare
professionals, has been lacking. The current absence of
strong evidence for diet-PC links means that provision
of disease-specific dietary advice can be neither system-
atic nor routine, although this study showed that men’s
interest in dietary information was high and that patients
may consider any dietary advice better than none. In par-
ticular, men undergoing non-radical treatment may benefit
from focusing on dietary change to help them manage
AM-related uncertainty [25,29]. More anxious patients may
also want more information on a ‘prostate-friendly’ diet
[30]. Thus there are opportunities for healthcare profes-
sionals to assist PC patients both clinically and psychologic-
ally by the routine integration of healthy eating advice into
survivorship care plans [31,32], particularly for men
embarking on AS/AM programmes who may have frequent
monitoring appointments over a long period. This may be
increasingly important with the increasing use of non-
radical approaches in men with low-risk disease worldwide
[20] and the lack of other actions that can be taken [33,34].
Targeting dietary information at both men and their part-
ners may encourage shared responsibility and strengthen
men’s rationales to make positive dietary changes.
Conclusions
The diagnosis of prostate cancer (PC) can prompt men
to adopt a healthier diet, which may improve quality of
life and clinical outcomes. However, men’s views about
dietary change in PC survivorship are largely unknown.
Many men make positive dietary changes after PC diagno-
sis, which are perceived to bring psychological and general
health benefits and could help future dietary intervention
trials. Men’s partners have an important role in supporting
them to make positive dietary changes, but uncertainty
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around the potential benefits of healthy eating after diagno-
sis may prevent dietary change. In particular, men and their
partners desire more and better dietary information that
may support PC survivorship, particularly among those
embarking on active surveillance/monitoring programmes.
There are opportunities for healthcare professionals to sup-
port PC patients both clinically and psychologically by the
routine integration of healthy eating advice into survivor-
ship care plans.
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